IntraLase Enhances Manufacturing, Quality and Productivity Focus with New Hires; William Wright - V.P. of Operations; Stephen McCusker - V.P. of Supply Chain Management

"With Bill's background and expertise in lean manufacturing,six-sigma quality, and rapid product commercialization, and Stephen'simpressive track record in developing global supply planningprocesses, IntraLase is expertly equipped to accelerate our efforts inworld-class manufacturing," stated Robert J. Palmisano, President andChief Executive Officer. "Both Bill and Stephen have tremendousexperience and are a welcome addition to the IntraLase managementteam."

Wright has held Senior Management positions in Operations,Manufacturing and Quality Systems for over 25 years with companies inthe medical device, diagnostics, biotechnology, and consumer productsfields. Most recently, Wright was Vice President of Operations atCytyc Surgical Products in Mountain View, Calif. Notably, Wright spent11 years at Baxter Healthcare Corp. between 1984 and 1995 in variouspositions, including Vice President of Manufacturing and ConsumableProduct Development for the Paramax Division.

McCusker has 20 years professional experience in Planning, SupplyChain Management, Contract Manufacturing Partnerships, Manufacturingand ERP Systems and implementations. He joined IntraLase after servingas Vice President of Operations at AutoGenomics Inc. and prior to thatheld positions in Senior Management of Operations and Supply Chain atBayer Healthcare and Quest Diagnostics/NID.

About IntraLase Corp.

IntraLase designs, develops, and manufactures an ultra-fast laserthat is revolutionizing refractive and corneal surgery by creatingsafe and more precise corneal incisions. Delivering on the promise ofophthalmic laser technology, the IntraLase FS laser, related software,and disposable devices replace the hand-held microkeratome blade usedduring LASIK surgery. The unsurpassed accuracy of IntraLase'scomputer-controlled femtosecond laser has been shown to improve safetyprofiles and visual outcomes when used during LASIK. Additionally, theIntraLase FS laser creates precision-designed intracorneal incisionsthat when combined can be used during lamellar and penetratingkeratoplasties, and intrastromal ring implantation. IntraLase ispresently in the process of commercializing applications of itstechnology in the treatment of corneal diseases that require cornealtransplant surgery. The company's proprietary laser and disposablepatient interfaces are presently marketed throughout the United Statesand 31 other countries. IntraLase has headquarters and manufacturesits products in Irvine. For additional information, visit thecompany's Web site: www.intralase.com.

Forward-Looking Statements

Statements contained in this press release that are not historicalinformation are forward-looking statements as defined within thePrivate Securities Litigation Reform Act of 1995. Forward-lookingstatements can be identified by the use of words such as "believe,""expect," "anticipate," "intend," "plan," "estimate," "project," orwords of similar meaning, or future or conditional verbs such as"will," "would," "should," "could," or "may." Such forward-lookingstatements are subject to risks and uncertainties that could causeactual results to differ materially from those projected or implied.Those risks and uncertainties include, but are not limited to: thedegree of continued acceptance of LASIK surgery; potentialcomplications revealed by long-term follow up; the extent of adoptionof our product offering by LASIK surgeons; general economicconditions; changes in federal tax laws governing the ability ofpotential LASIK patients to use pre-tax dollars to pay for LASIKsurgery; the scope of government regulation applicable to ourproducts; patients' willingness to pay for LASIK surgery; our abilityto compete against our competitors; the effectiveness of our measuresto ensure full payment of procedure fees; the occurrence and outcomeof product liability suits against us; our ability to adequatelyprotect our intellectual property; whether we become subject to claimsof infringement or misappropriation of the intellectual propertyrights of others; the continued availability of supplies fromsingle-source suppliers and manufacturers of our key laser components;the ability of our managers, operations, and facilities to manage ourgrowth; the success of our expansion into markets outside the UnitedStates; whether we lose any of our key executives or fail to attractqualified personnel; or if our new products or applications fail tobecome commercially viable.

Certain of these risks and uncertainties, in addition to otherrisks, are more fully described in the company's quarterly report onForm 10-Q for the period ending June 30, 2006, as filed with theSecurities and Exchange Commission on Aug. 1, 2006.

These forward-looking statements are made only as of the date ofthis press release, and the company assumes no obligation to update orrevise the forward-looking statements, whether as a result of newinformation, future events, or otherwise.